(Q46697324)

24 December 2017

title

Relationship between gamma-glutamyltransferase and metabolic syndrome in a Korean population (English)

1 reference

24 December 2017

1 reference

M Y Lee

1

1 reference

24 December 2017

S B Koh

2

1 reference

24 December 2017

J H Koh

3

1 reference

24 December 2017

S M Nam

4

1 reference

24 December 2017

J Y Shin

5

1 reference

24 December 2017

Y G Shin

6

1 reference

24 December 2017

I D Kong

7

1 reference

24 December 2017

S Y Ryu

8

1 reference

24 December 2017

T Y Lee

9

1 reference

24 December 2017

J K Park

10

1 reference

24 December 2017

C H Chung

11

1 reference

24 December 2017

publication date

13 March 2008

1 reference

24 December 2017

published in

Diabetic Medicine

1 reference

24 December 2017

volume

25

1 reference

24 December 2017

issue

4

1 reference

24 December 2017

page(s)

469-475

1 reference

24 December 2017

Oxidative stress and dysregulation of NAD(P)H oxidase and antioxidant enzymes in diet-induced metabolic syndrome

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Associations between gamma-glutamyl transferase, metabolic abnormalities and inflammation in healthy subjects from a population-based cohort: a possible implication for oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Gamma-glutamyltransferase is a predictor of incident diabetes and hypertension: the Coronary Artery Risk Development in Young Adults (CARDIA) Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Serum gamma-glutamyltransferase within its normal concentration range is related to the presence of diabetes and cardiovascular risk factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Association between gamma-glutamyl transpeptidase activity and status of disorders constituting insulin resistance syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Liver enzymes, the metabolic syndrome, and incident diabetes: the Mexico City diabetes study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Hepatic enzymes, the metabolic syndrome, and the risk of type 2 diabetes in older men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Identification of differentially expressed genes in skeletal muscle of non-diabetic insulin-resistant and insulin-sensitive Pima Indians by differential display PCR

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Geographical difference in the prevalence of isolated systolic hypertension in middle-aged men and women in Korea: the Korean Health and Genome Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Appropriate waist circumference cutoff points for central obesity in Korean adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Gamma glutamyl transferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Induction of hepatic microsomal gamma-glutamyltransferase activity following chronic alcohol consumption

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Is serum gamma-glutamyltransferase inversely associated with serum antioxidants as a marker of oxidative stress?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Gamma-glutamyltransferase, alcohol, and blood pressure. A four year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Gamma-glutamyltransferase and risk of stroke: the EUROSTROKE project

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Role of oxidative modifications in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Elevated serum levels of alanine aminotransferase and gamma glutamyltransferase are markers of inflammation and oxidative stress independent of the metabolic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Serum gamma-glutamyltransferase and risk of metabolic syndrome and type 2 diabetes in middle-aged Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Elevated serum GGT concentrations predict reduced insulin sensitivity and increased intrahepatic lipids

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

The adipocyte-secreted protein Acrp30 enhances hepatic insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Adiponectin, an adipocyte-derived plasma protein, inhibits endothelial NF-kappaB signaling through a cAMP-dependent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

C-reactive protein and glycemic control in adults with diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Should C-reactive protein be added to metabolic syndrome and to assessment of global cardiovascular risk?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Inflammation-induced vasoconstrictorhyporeactivity is caused by oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

High alanine aminotransferase is associated with decreased hepatic insulin sensitivity and predicts the development of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Nonalcoholic fatty liver disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Insulin resistance, insulin response, and obesity as indicators of metabolic risk

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

Serum gamma-glutamyltransferase and risk of type 2 diabetes mellitus in men and women from the general population

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2008.02415.X

10.1111/J.1464-5491.2008.02415.X

21 January 2018

Identifiers

DOI

1 reference

24 December 2017

1 reference

24 December 2017